Komori
GNI Group (2160) · InitiativeAdvanced

Building a Japanese Dental Laboratory Business Platform Through the Acquisition of ZOO LABO

First written in FY2025. 2 of 3 entries say "Advanced", first in 2026-05-15. Latest entry: FY2026-H1.

3entries
1years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-05-15 – FY2026-H12026: 32026
Same theme, other companies

No other company in this theme has enough history to compare yet.

Moved together

"Business expansion with Japan as the third business pillar" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Business expansion with Japan as the third business pillar2×
  3. 2Development of an RP indication for アイスーリュイ (pirfenidone)2×
  4. 3F351 China Phase 2 Clinical Trial2×
  5. 4Development of Eisai’s Iusuryu for pneumoconiosis2×
  6. 5Diversification and Stabilization of Funding2×
  7. 6CG001419 (TRK degrader): China IND approval and Phase I preparations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for GNI Group yet. It last moved in the Earnings presentation of 2026-05-15: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.